Crapo emphasizes the need to address drug cost benchmarks.
03/30/2023
https://www.congress.gov...
Some want the IRS to prepare tax returns for taxpayers, and several colleagues have actually introduced legislation in C...
When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few diffe...
Obviously, transparency is key.
Planning for that is something that we have just done poorly because we continue to see flood insurance and flood challe...